1. Home
  2. HBT vs AORT Comparison

HBT vs AORT Comparison

Compare HBT & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HBT Financial Inc.

HBT

HBT Financial Inc.

HOLD

Current Price

$35.75

Market Cap

1.2B

Sector

Finance

ML Signal

HOLD

Logo Artivion Inc.

AORT

Artivion Inc.

HOLD

Current Price

$28.08

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HBT
AORT
Founded
1920
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.4B
IPO Year
2019
1996

Fundamental Metrics

Financial Performance
Metric
HBT
AORT
Price
$35.75
$28.08
Analyst Decision
Buy
Strong Buy
Analyst Count
5
5
Target Price
$30.75
$49.40
AVG Volume (30 Days)
131.6K
697.0K
Earning Date
04-27-2026
05-07-2026
Dividend Yield
3.29%
N/A
EPS Growth
7.96
165.62
EPS
1.12
N/A
Revenue
N/A
$298,836,000.00
Revenue This Year
$35.73
$14.20
Revenue Next Year
$7.01
$11.20
P/E Ratio
$31.66
N/A
Revenue Growth
N/A
18.01
52 Week Low
$22.36
$19.16
52 Week High
$37.51
$48.25

Technical Indicators

Market Signals
Indicator
HBT
AORT
Relative Strength Index (RSI) 54.14 57.96
Support Level $35.34 $25.79
Resistance Level $37.17 $38.02
Average True Range (ATR) 0.78 1.28
MACD -0.28 -0.04
Stochastic Oscillator 23.72 57.61

Price Performance

Historical Comparison
HBT
AORT

About HBT HBT Financial Inc.

HBT Financial Inc provides a comprehensive suite of business, commercial, wealth management, and retail banking products and services to individuals, businesses, and municipal entities throughout Central and Northeastern Illinois and Eastern Iowa. It operates through one reportable segment: community banking. It generates revenue from Card income, Wealth management fees, and Service charges on deposit accounts.

About AORT Artivion Inc.

Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.

Share on Social Networks: